Levetiracetam
Product Images NDC 21695-071

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 21695-071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 01)

Chemical structure of levetiracetam depicting the molecular arrangement including a pyrrolidone ring, ethyl side chain, hydrogen atom, and amide group as part of its active ingredient composition.*

FDA Label Image

Image (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 02)

A bar chart showing the percentage of patients by treatment group: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. Percentages increase from placebo (7.4%) to 1000 mg/day (37.1%) to 3000 mg/day (39.6%). Statistical significance versus placebo is noted with an asterisk for both Levetiracetam groups.*

FDA Label Image

Image (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 03)

A vertical bar chart depicting the percentage of patients for three groups: placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The chart includes sample sizes for each group and indicates statistically significant differences from placebo with asterisks.*

FDA Label Image

Image (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 04)

A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The chart shows 14.4% of patients for the placebo group (N=104) and 39.4% for the Levetiracetam group (N=180), with a notation indicating statistical significance versus placebo.*

FDA Label Image

Image (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 05)

A bar chart comparing the percentage of patients with a specific outcome between placebo and levetiracetam groups. The chart shows about 19.6% for placebo (N=97) and 44.6% for levetiracetam (N=101), with a note indicating statistical significance between groups.*

FDA Label Image

Logo (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 06)

FDA Label Image

Logo (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 07)

FDA Label Image

Levetiracetam 250mg (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 08)

Levetiracetam 250 mg tablets label from Physician Partner, a division of Rebel Distributors Corp. The label identifies the product as 250 mg strength with 60 tablets per package. It includes lot and expiration date fields, indicates prescription-only status, and states the drug is manufactured by Torrent Pharmaceuticals Ltd. in India. Storage information and a caution to keep medication out of reach of children are included.*

FDA Label Image

Levetiracetam 500mg (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 09)

Label for Levetiracetam 500 mg tablets, bottle count of 60. It states each tablet contains 500 mg of Levetiracetam. The tablets are described as yellow, oval shaped, film-coated with specific debossing. Labeler stated as Rebel Distributors Corp, packaged by Physician Partner, Thousand Oaks, CA. Includes NDC 21695-006-60 and storage information.*

FDA Label Image

Levetiracetam 1000mg (76c7e13d 37a0 4131 A1f1 Fd5af0f60d3e 10)

Label for Levetiracetam 1000 mg tablets, showing 60 tablets per container. The label includes the NDC number 21695-016-60, states each tablet contains 1000 mg of Levetiracetam USP, and notes the tablets are white to off-white, oval-shaped, film-coated with debossed markings. Manufactured by Torrent Pharmaceuticals Ltd., India, and distributed by Physician Partner, Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.